Blood serum amino acids profile in patients with Multiple Sclerosis

Current Issues in Pharmacy and Medical Sciences

Volumn 26, Issue 1, 2013, Pages 50-53

  Jakubowska Solarska, Beata ^a   Niespialowska, Magdalena ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Amino acid; Aspartic acid; Glutamic acid; Multiple sclerosis (MS); Taurine

Indexed keywords

AMINO ACID; ASPARTIC ACID; GLUTAMIC ACID; NEUROTRANSMITTER; TAURINE;

ADULT; AMINO ACID ANALYSIS; AMINO ACID BLOOD LEVEL; ARTICLE; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DEMYELINATING DISEASE; DISEASE COURSE; EXPANDED DISABILITY STATUS SCALE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; MULTIPLE SCLEROSIS; MYELIN SHEATH; NEUROTRANSMISSION; PROTEOMICS; SERUM; SEX DIFFERENCE;

EID: 84882754790     PISSN: 2084980X     EISSN: None     Source Type: Journal    
DOI: 10.12923/j.2084-980X/26.1/a.10     Document Type: Article

References (24)

1. Bark hatova V.P. et al.: Changes inneurotransmit ters in multiple sclerosis. Neurosci Behav Physiol, 28, 4, 1998.
2. Bates Ian R., et al.: An Arg/Lys Gln mu tant of re com binant murine mye lin basic protein as a mimic of the de iminated form im plicated in multiple sclerosis. Protein Expr Pu rif, 25, 330-341, 2002.
3. Fernando D.: Sclerosis Multiple. Neurology, 2010.
4. Gauderman W-J, Cozen W, Mack T-M.: Child hood sun ex-posure in fluences risk of multiple sclerosis in mono zy gotictwins Talat Is lam. Neurology, 69, 381-388, 2007
5. Haf ler D.A. et al.: Risk Al leles for Multiple Sclerosis Identi-fied by a Genomewide Study. N Eng J Med, 357 (9), 851-862, 2007.
6. Haines J.D, In glese M, Casac cia P.: Ax onal Dam age in Mul-tiple Sclerosis. Mt Sinai J Med, 78(2), 231-243, 2011.
7. Harauz G., Ab di wa hab A. Musse.: A Tale of Two Citrul li-nes-Structural and Functional As pects of Myelin Basic Protein De imination in Healthand Dis ease. Neurochem Res, 32, 137-158, 2007.
8. Lassmann H.: Ex perimental models of multiple sclerosis. Rev Neurol, 163(6-7), 651-655, 2007.
9. Levin LI, et al.: Temporal relation ship betweenelevation of epstein-barrvirus anti body titers and initial on set ofneuro-logical symp toms in multiple sclerosis. JAMA, 2496-2500, 2005.
10. Liberski P.P. et al. (2005). Choroby demielinizacy jne . Neu-ropatolo gia Mossakowskiego. Lublin: Wy dawnictwo Cze lej; p.161-174.
11. Lucchinetti C, et al.: Hetero geneity of multiple sclerosis le-sions: im plications for the patho genesis of demyelination. Ann Neurol, 47 (6), 707-717, 2000.
12. Mou zaki A, et al.: Re mitting-relapsing multiple sclerosis pa-tient re fractory tocon ventionaltreat ments and bone mar-row trans plantation whore sponded to natalizu mab. Int J Gen Med, 3, 313-320, 2010.
13. Mun ger K-L. et al.: Serum 25-Hydroxyvitamin D Lev els and Risk of Multiple Sclerosis. JAMA, 296 (23), 2832-2838, 2006.
14. Pas cual AM, et al.: Ax onal loss is pro gressive and partly dis-soci ated fromlesion load in early multiple sclerosis. Neu-rology, 69 (1), 63-67, 2007.
15. Pierrot-Deseilligny C.: Clinicalimplications of apossi blerole of vita min D in multiple sclerosis. J Neurol, 1468-1479, 2009.
16. Pon sonby A.-L. et al.: Ex posureto In fant Sib lings Dur ing Early Life and Risk of Multiple Sclerosis. JAMA, 293(4), 463-469, 2005.
17. Renoux C. et al.: Natu ral History of Multiple Sclerosis with Childhood On set. N Engl J Med, 356, 2603-13, 2007.
18. Rent zos M. et al.: Serum uric acid and multiple sclerosis. Clin NeurolNeurosurg, 108 (6), 527-531, 2006.
19. Richard A. et al.: Gray-Matter In juryin Multiple Sclerosis. N Eng J Med, 361(15), 1505-1506, 2009.
20. Srini vasan R. et al.: Evi dence of elevated glu ta mate in multi-ple sclerosis using mag netic reso nance spectros copy at 3 T. Brain, 128, 1016-1025, 2005.
21. Sternberg Z. et al.: Acam prosate modulates experimental auto im mune en cephalomye litis. In flam mopharmacology, 20(1), 39-48, 2012.
22. Su Kimmy G. et al.: Ax onalde generation in multiple sclero-sis: The mitochon drial hy potesis. Curr NeurolNeurosci Rep, 9(5), 411-417, 2009.
23. Vi glietta V. et al.: Loss offunctional suppression by CD4+CD25+ regulatory T cells inpatients with multiple sclerosis. J Exp Med, 199 (7), 971-979, 2004.
24. Zabocka A., Janusz M.: Structure and function of the central nerv oussystem. Pos tepy Hig Med Dosw (on line), 61, 454-460, 2007.